Deborah Elstein

Novel oral treatment of Gaucher's disease with N-butyldeoxynojirimycin (OGT 918) to decrease substrate biosynthesis

Timothy M. Cox, Robin Lachmann, C. E. Hollak et al. · The Lancet · 2000 · 744 citations

Medicine, Pharmacology, Pharmacotherapy +4

Occurrence of Parkinson's syndrome in type 1 Gaucher disease

Orit Neudorfer, Nir Giladi, Deborah Elstein et al. · QJM · 1996 · 396 citations · Full text

Medicine, Neurology, Neuroscience +17

Sustained therapeutic effects of oral miglustat (Zavesca, <i>N</i>‐butyldeoxynojirimycin, OGT 918) in type I Gaucher disease

Deborah Elstein, Carla E. M. Hollak, Johannes M. F. G. Aerts et al. · Journal of Inherited Metabolic Disease · 2004 · 233 citations

Pharmacy, Pharmacotherapy, Neurobiology Of Disease +3

Comparison of Parkinson Risk in Ashkenazi Jewish Patients With Gaucher Disease and<i>GBA</i>Heterozygotes

Roy N. Alcalay, Tama Dinur, Timothy J. Quinn et al. · JAMA Neurology · 2014 · 220 citations · Full text

Life Sciences, Genetics, Neurology +17

Gaucher's disease variant characterised by progressive calcification of heart valves and unique genotype

Aya Abrahamov, Deborah Elstein, Ari Zimran et al. · The Lancet · 1995 · 212 citations

Medicine, Genetics, Molecular Genetics +17